U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 193

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr11:32456744
GRCh38:
Chr11:32435198
LOC107982234, WT1A50T, A55TWilms tumor 1, Aniridia 1, Meacham syndrome,
Nephrotic syndrome, type 4, Drash syndrome, 11p partial monosomy syndrome,
Frasier syndrome, Mesothelioma, malignant
Uncertain significance
(Feb 4, 2022)
criteria provided, single submitter
2.
GRCh37:
Chr11:32414244
GRCh38:
Chr11:32392698
WT1D187V, D207V, D224V, D383V, D400V, D419V, D424V, D436V, D439V, D441V, D45VNephrotic syndrome, type 4Likely pathogenic
(Jan 14, 2022)
criteria provided, single submitter
3.
GRCh37:
Chr11:32449488
GRCh38:
Chr11:32427942
WT1Aniridia 1, Meacham syndrome, Mesothelioma, malignant,
Drash syndrome, Nephrotic syndrome, type 4, Wilms tumor 1,
Frasier syndrome, 11p partial monosomy syndrome, Drash syndrome,
Wilms tumor 1, Frasier syndrome11p partial monosomy syndrome,
...see more
Benign/Likely benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
4.
GRCh37:
Chr11:32417784
GRCh38:
Chr11:32396238
WT1Drash syndrome, Frasier syndrome, Wilms tumor 1,
11p partial monosomy syndrome, Aniridia 1, Meacham syndrome,
Drash syndrome, Mesothelioma, malignant, Nephrotic syndrome, type 4,
Frasier syndrome, Wilms tumor 111p partial monosomy syndrome,
...see more
Likely benign
(Oct 19, 2022)
criteria provided, multiple submitters, no conflicts
5.
GRCh37:
Chr11:32438021
GRCh38:
Chr11:32416475
WT1Drash syndrome, Frasier syndrome, Wilms tumor 1,
11p partial monosomy syndrome, Aniridia 1, Meacham syndrome,
Drash syndrome, Mesothelioma, malignant, Nephrotic syndrome, type 4,
Frasier syndrome, Wilms tumor 111p partial monosomy syndrome,
...see more
Likely benign
(Oct 27, 2022)
criteria provided, multiple submitters, no conflicts
6.
GRCh37:
Chr11:32450047
GRCh38:
Chr11:32428501
WT1Wilms tumor 1, 11p partial monosomy syndrome, Drash syndrome,
Frasier syndrome, Aniridia 1, Mesothelioma, malignant,
Wilms tumor 1, 11p partial monosomy syndrome, Drash syndrome,
Nephrotic syndrome, type 4, Frasier syndromeMeacham syndrome,
...see more
Likely benign
(Nov 30, 2021)
criteria provided, multiple submitters, no conflicts
7.
GRCh37:
Chr11:32456231
GRCh38:
Chr11:32434685
LOC107982234, WT1Drash syndrome, Wilms tumor 1, Frasier syndrome,
11p partial monosomy syndrome, Mesothelioma, malignant, Meacham syndrome,
Drash syndrome, Wilms tumor 1, Frasier syndrome,
11p partial monosomy syndrome, Aniridia 1Nephrotic syndrome, type 4,
...see more
Conflicting interpretations of pathogenicity
(Sep 1, 2022)
criteria provided, conflicting interpretations
8.
GRCh37:
Chr11:32449618
GRCh38:
Chr11:32428072
WT1Drash syndrome, Wilms tumor 1, 11p partial monosomy syndrome,
Frasier syndrome, Aniridia 1, Drash syndrome,
Meacham syndrome, Mesothelioma, malignant, Nephrotic syndrome, type 4,
Wilms tumor 1, 11p partial monosomy syndromeFrasier syndrome,
...see more
Uncertain significance
(Jul 29, 2022)
criteria provided, multiple submitters, no conflicts
9.
GRCh37:
Chr11:32449483
GRCh38:
Chr11:32427937
WT1Meacham syndrome, Mesothelioma, malignant, Wilms tumor 1,
11p partial monosomy syndrome, Frasier syndrome, Aniridia 1,
Nephrotic syndrome, type 4, Drash syndrome, Wilms tumor 1,
11p partial monosomy syndrome, Frasier syndromeDrash syndrome,
...see more
Conflicting interpretations of pathogenicity
(Aug 31, 2022)
criteria provided, conflicting interpretations
10.
GRCh37:
Chr11:32456448
GRCh38:
Chr11:32434902
LOC107982234, WT1Wilms tumor 1, 11p partial monosomy syndrome, Frasier syndrome,
Drash syndrome, Wilms tumor 1, 11p partial monosomy syndrome,
Nephrotic syndrome, type 4, Frasier syndrome, Aniridia 1,
Drash syndrome, Meacham syndromeMesothelioma, malignant,
...see more
Conflicting interpretations of pathogenicity
(Oct 25, 2022)
criteria provided, conflicting interpretations
11.
GRCh37:
Chr11:32410639
GRCh38:
Chr11:32389093
WT1Q116*, Q278*, Q292*, Q492*, Q509*, Q512*, Q464*, Q454*, Q465*, Q490*, Q495*, Q507*, Q258*, Q468*, Q481*Nephrotic syndrome, type 4Pathogeniccriteria provided, single submitter
12.
GRCh37:
Chr11:32417940
GRCh38:
Chr11:32396394
WT1V359A, V142A, V376A, V159A, V318A, V371A, V335A, V354A, V374A, V122ADrash syndrome, Wilms tumor 1, 11p partial monosomy syndrome,
Frasier syndrome, Mesothelioma, malignant, Aniridia 1,
Drash syndrome, Meacham syndrome, Wilms tumor 1,
11p partial monosomy syndrome, Nephrotic syndrome, type 4Frasier syndrome,
...see more
Uncertain significance
(Mar 16, 2022)
criteria provided, multiple submitters, no conflicts
13.
GRCh37:
Chr11:32438063
GRCh38:
Chr11:32416517
WT1S113L, S330L, S289L, S325L, S76LFrasier syndrome, Drash syndrome, Wilms tumor 1,
11p partial monosomy syndrome, Nephrotic syndrome, type 4, Aniridia 1,
Frasier syndrome, Drash syndrome, Meacham syndrome,
Mesothelioma, malignant, Wilms tumor 111p partial monosomy syndrome,
...see more
Uncertain significance
(Sep 7, 2022)
criteria provided, multiple submitters, no conflicts
14.
GRCh37:
Chr11:32456629
GRCh38:
Chr11:32435083
LOC107982234, WT1G93ANephrotic syndrome, type 4Pathogenic
(Apr 1, 2020)
criteria provided, single submitter
15.
GRCh37:
Chr11:32456657
GRCh38:
Chr11:32435111
LOC107982234, WT1Nephrotic syndrome, type 4Pathogenic
(Apr 1, 2020)
criteria provided, single submitter
16.
GRCh37:
Chr11:32417905
GRCh38:
Chr11:32396359
WT1S171P, S388P, S371P, S154P, S347P, S386P, S330P, S366P, S383P, S134PFrasier syndrome, Aniridia 1, Nephrotic syndrome, type 4,
Wilms tumor 1, 11p partial monosomy syndrome, Drash syndrome,
Meacham syndrome, Mesothelioma, malignant, Frasier syndrome,
Wilms tumor 1, 11p partial monosomy syndromeDrash syndrome,
...see more
Uncertain significance
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
17.
GRCh37:
Chr11:32450105
GRCh38:
Chr11:32428559
WT1A241V, A24V, A236VFrasier syndrome, Aniridia 1, Nephrotic syndrome, type 4,
Wilms tumor 1, 11p partial monosomy syndrome, Drash syndrome,
Meacham syndrome, Mesothelioma, malignant, Frasier syndrome,
Wilms tumor 1, 11p partial monosomy syndromeDrash syndrome,
...see more
Uncertain significance
(Dec 21, 2021)
criteria provided, multiple submitters, no conflicts
18.
GRCh37:
Chr11:32456254
GRCh38:
Chr11:32434708
LOC107982234, WT1R218HDrash syndrome, Frasier syndrome, Wilms tumor 1,
11p partial monosomy syndrome, Aniridia 1, Meacham syndrome,
Drash syndrome, Mesothelioma, malignant, Nephrotic syndrome, type 4,
Frasier syndrome, Wilms tumor 111p partial monosomy syndrome,
...see more
Uncertain significance
(Dec 6, 2021)
criteria provided, multiple submitters, no conflicts
19.
GRCh37:
Chr11:32456556
GRCh38:
Chr11:32435010
LOC107982234, WT1Drash syndrome, Frasier syndrome, Wilms tumor 1,
11p partial monosomy syndrome, Aniridia 1, Meacham syndrome,
Drash syndrome, Mesothelioma, malignant, Nephrotic syndrome, type 4,
Frasier syndrome, Wilms tumor 111p partial monosomy syndrome,
...see more
Uncertain significance
(Aug 31, 2021)
criteria provided, multiple submitters, no conflicts
20.
GRCh37:
Chr11:32417814
GRCh38:
Chr11:32396268
WT1R184M, R201M, R418M, R22M, R401M, R360M, R377M, R413M, R164M, R396M, R416MDrash syndrome, Frasier syndrome, Wilms tumor 1,
11p partial monosomy syndrome, Meacham syndrome, Mesothelioma, malignant,
Aniridia 1, Drash syndrome, Nephrotic syndrome, type 4,
Frasier syndrome, Wilms tumor 111p partial monosomy syndrome,
...see more
Uncertain significance
(Sep 14, 2022)
criteria provided, multiple submitters, no conflicts
21.
GRCh37:
Chr11:32410614
GRCh38:
Chr11:32389068
WT1L517P, L300P, L520P, L124P, L286P, L500P, L266P, L473P, L515P, L472P, L503P, L489P, L462P, L476P, L498PDrash syndrome, Frasier syndrome, Wilms tumor 1,
11p partial monosomy syndrome, Inborn genetic diseases, Meacham syndrome,
Mesothelioma, malignant, Aniridia 1, Drash syndrome,
Nephrotic syndrome, type 4, Frasier syndromeWilms tumor 1,
11p partial monosomy syndrome, ...see more
Uncertain significance
(Sep 27, 2022)
criteria provided, multiple submitters, no conflicts
22.
GRCh37:
Chr11:32456261
GRCh38:
Chr11:32434715
LOC107982234, WT1A216TAniridia 1, Drash syndrome, Meacham syndrome,
Frasier syndrome, Mesothelioma, malignant, Wilms tumor 1,
11p partial monosomy syndrome, Nephrotic syndrome, type 4, Drash syndrome,
Frasier syndrome, Wilms tumor 111p partial monosomy syndrome,
...see more
Uncertain significance
(Aug 27, 2022)
criteria provided, multiple submitters, no conflicts
23.
GRCh37:
Chr11:32449576
GRCh38:
Chr11:32428030
WT1Wilms tumor 1, 11p partial monosomy syndrome, Drash syndrome,
Frasier syndrome, Meacham syndrome, Nephrotic syndrome, type 4,
Wilms tumor 1, not specified
Conflicting interpretations of pathogenicity
(Sep 28, 2022)
criteria provided, conflicting interpretations
24.
GRCh37:
Chr11:32410504
GRCh38:
Chr11:32388958
WT1Wilms tumor 1, Meacham syndrome, Nephrotic syndrome, type 4
Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
25.
GRCh37:
Chr11:32409538
GRCh38:
Chr11:32387992
WT1Wilms tumor 1, Meacham syndrome, Nephrotic syndrome, type 4
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
26.
GRCh37:
Chr11:32438079
GRCh38:
Chr11:32416533
WT1A108T, A325T, A71T, A284T, A320TWilms tumor 1, 11p partial monosomy syndrome, Drash syndrome,
Frasier syndrome, Meacham syndrome, Nephrotic syndrome, type 4,
Wilms tumor 1
Uncertain significance
(Oct 1, 2021)
criteria provided, multiple submitters, no conflicts
27.
GRCh37:
Chr11:32409975
GRCh38:
Chr11:32388429
WT1Meacham syndrome, Wilms tumor 1, Nephrotic syndrome, type 4
Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
28.
GRCh37:
Chr11:32410599
GRCh38:
Chr11:32389053
WT1Meacham syndrome, Wilms tumor 1, Nephrotic syndrome, type 4
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
29.
GRCh37:
Chr11:32410592
GRCh38:
Chr11:32389046
WT1Meacham syndrome, Wilms tumor 1, Nephrotic syndrome, type 4
Conflicting interpretations of pathogenicity
(Jan 12, 2018)
criteria provided, conflicting interpretations
30.
GRCh37:
Chr11:32456993
GRCh38:
Chr11:32435447
LOC107982234, WT1Meacham syndrome, Wilms tumor 1, Nephrotic syndrome, type 4
Uncertain significance
(Mar 2, 2018)
criteria provided, single submitter
31.
GRCh37:
Chr11:32456609
GRCh38:
Chr11:32435063
LOC107982234, WT1P100AMeacham syndrome, Wilms tumor 1, Nephrotic syndrome, type 4
Uncertain significance
(Apr 27, 2017)
criteria provided, single submitter
32.
GRCh37:
Chr11:32421587
GRCh38:
Chr11:32400041
WT1Wilms tumor 1, 11p partial monosomy syndrome, Drash syndrome,
Frasier syndrome, Meacham syndrome, Nephrotic syndrome, type 4,
Wilms tumor 1
Conflicting interpretations of pathogenicity
(Oct 25, 2022)
criteria provided, conflicting interpretations
33.
GRCh37:
Chr11:32456407
GRCh38:
Chr11:32434861
LOC107982234, WT1V167D, V162DNephrotic syndrome, type 4Likely pathogenic
(Jan 24, 2020)
criteria provided, single submitter
34.
GRCh37:
Chr11:32456881
GRCh38:
Chr11:32435335
LOC107982234, WT1P9LDrash syndrome, Frasier syndrome, Wilms tumor 1,
11p partial monosomy syndrome, Aniridia 1, Nephrotic syndrome, type 4,
Drash syndrome, Frasier syndrome, Meacham syndrome,
Mesothelioma, malignant, Wilms tumor 111p partial monosomy syndrome,
...see more
Uncertain significance
(Aug 1, 2022)
criteria provided, multiple submitters, no conflicts
35.
GRCh37:
Chr11:32456279
GRCh38:
Chr11:32434733
LOC107982234, WT1C210GDrash syndrome, Frasier syndrome, Wilms tumor 1,
11p partial monosomy syndrome, Aniridia 1, Nephrotic syndrome, type 4,
Drash syndrome, Frasier syndrome, Meacham syndrome,
Mesothelioma, malignant, Wilms tumor 111p partial monosomy syndrome,
Wilms tumor 1, ...see more
Uncertain significance
(Oct 28, 2022)
criteria provided, multiple submitters, no conflicts
36.
GRCh37:
Chr11:32456287
GRCh38:
Chr11:32434741
LOC107982234, WT1L207Rnot provided, Nephrotic syndrome, type 4, Wilms tumor 1,
11p partial monosomy syndrome, Frasier syndrome, Drash syndrome,
Wilms tumor 1, Meacham syndrome
Uncertain significance
(May 31, 2022)
criteria provided, multiple submitters, no conflicts
37.
GRCh37:
Chr11:32456594
GRCh38:
Chr11:32435048
LOC107982234, WT1A105SWilms tumor 1, Drash syndrome, Frasier syndrome,
Wilms tumor 1, 11p partial monosomy syndrome, Meacham syndrome,
Nephrotic syndrome, type 4
Uncertain significance
(Sep 1, 2021)
criteria provided, multiple submitters, no conflicts
38.
GRCh37:
Chr11:32456505
GRCh38:
Chr11:32434959
LOC107982234, WT1Wilms tumor 1, Meacham syndrome, Frasier syndrome,
Wilms tumor 1, 11p partial monosomy syndrome, Drash syndrome,
not specified, Nephrotic syndrome, type 4
Conflicting interpretations of pathogenicity
(Jan 12, 2023)
criteria provided, conflicting interpretations
39.
GRCh37:
Chr11:32456792
GRCh38:
Chr11:32435246
LOC107982234, WT1Hereditary cancer-predisposing syndrome, Frasier syndrome, Wilms tumor 1,
11p partial monosomy syndrome, Drash syndrome, Frasier syndrome,
Nephrotic syndrome, type 4, Wilms tumor 1, 11p partial monosomy syndrome,
Aniridia 1, Meacham syndromeMesothelioma, malignant,
Drash syndrome, ...see more
Likely benign
(Aug 3, 2022)
criteria provided, multiple submitters, no conflicts
40.
GRCh37:
Chr11:32456880
GRCh38:
Chr11:32435334
LOC107982234, WT1Hereditary cancer-predisposing syndrome, Aniridia 1, Frasier syndrome,
Nephrotic syndrome, type 4, Wilms tumor 1, 11p partial monosomy syndrome,
Drash syndrome, Meacham syndrome, Mesothelioma, malignant,
Frasier syndrome, Wilms tumor 111p partial monosomy syndrome,
Drash syndrome, ...see more
Likely benign
(Sep 20, 2022)
criteria provided, multiple submitters, no conflicts
41.
GRCh37:
Chr11:32410611
GRCh38:
Chr11:32389065
WT1A125V, A287V, A301V, A518V, A521V, A501V, A463V, A490V, A504V, A474V, A477V, A499V, A516V, A267V, A473VDrash syndrome, Frasier syndrome, Wilms tumor 1,
11p partial monosomy syndrome, Aniridia 1, Nephrotic syndrome, type 4,
Drash syndrome, Frasier syndrome, Wilms tumor 1,
Meacham syndrome, Mesothelioma, malignant11p partial monosomy syndrome,
not provided, ...see more
Uncertain significance
(Dec 13, 2022)
criteria provided, multiple submitters, no conflicts
42.
GRCh37:
Chr11:32456316
GRCh38:
Chr11:32434770
LOC107982234, WT1Q197HDrash syndrome, Frasier syndrome, Wilms tumor 1,
11p partial monosomy syndrome, Aniridia 1, Nephrotic syndrome, type 4,
Drash syndrome, Frasier syndrome, Wilms tumor 1,
Meacham syndrome, Mesothelioma, malignant11p partial monosomy syndrome,
...see more
Uncertain significance
(Aug 31, 2022)
criteria provided, multiple submitters, no conflicts
43.
GRCh37:
Chr11:32456684
GRCh38:
Chr11:32435138
LOC107982234, WT1G75SDrash syndrome, Frasier syndrome, Wilms tumor 1,
11p partial monosomy syndrome, Aniridia 1, Nephrotic syndrome, type 4,
Drash syndrome, Frasier syndrome, Wilms tumor 1,
Meacham syndrome, Mesothelioma, malignant11p partial monosomy syndrome,
...see more
Uncertain significance
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
44.
GRCh37:
Chr11:32417917
GRCh38:
Chr11:32396371
WT1V167I, V384I, V150I, V367I, V343I, V362I, V379I, V326I, V130I, V382IDrash syndrome, Frasier syndrome, Wilms tumor 1,
11p partial monosomy syndrome, Aniridia 1, Nephrotic syndrome, type 4,
Drash syndrome, Frasier syndrome, Wilms tumor 1,
Meacham syndrome, Mesothelioma, malignant11p partial monosomy syndrome,
...see more
Uncertain significance
(Sep 9, 2022)
criteria provided, multiple submitters, no conflicts
45.
GRCh37:
Chr11:32410686
GRCh38:
Chr11:32389140
WT1K476R, K496R, K262R, K493R, K100R, K276R, K438R, K452R, K448R, K449R, K242R, K479R, K465R, K474R, K491RAniridia 1, Meacham syndrome, Mesothelioma, malignant,
Wilms tumor 1, 11p partial monosomy syndrome, Drash syndrome,
Nephrotic syndrome, type 4, Frasier syndrome, Wilms tumor 1,
11p partial monosomy syndrome, Drash syndromeFrasier syndrome,
...see more
Uncertain significance
(Oct 22, 2021)
criteria provided, multiple submitters, no conflicts
46.
GRCh37:
Chr11:32456249
GRCh38:
Chr11:32434703
LOC107982234, WT1Q220Knot provided, Aniridia 1, Meacham syndrome,
Mesothelioma, malignant, Wilms tumor 1, 11p partial monosomy syndrome,
Drash syndrome, Nephrotic syndrome, type 4, Frasier syndrome,
Wilms tumor 1, 11p partial monosomy syndromeDrash syndrome,
Frasier syndrome, ...see more
Uncertain significance
(Jun 5, 2023)
criteria provided, multiple submitters, no conflicts
47.
GRCh37:
Chr11:32456521
GRCh38:
Chr11:32434975
LOC107982234, WT1P129QAniridia 1, Mesothelioma, malignant, Frasier syndrome,
Drash syndrome, Meacham syndrome, Wilms tumor 1,
11p partial monosomy syndrome, Nephrotic syndrome, type 4, Frasier syndrome,
Drash syndrome, Wilms tumor 111p partial monosomy syndrome,
...see more
Uncertain significance
(Aug 3, 2022)
criteria provided, multiple submitters, no conflicts
48.
GRCh37:
Chr11:32417851
GRCh38:
Chr11:32396305
WT1R189G, R406G, R389G, R10G, R172G, R365G, R404G, R384G, R152G, R348G, R401GNephrotic syndrome, type 4Uncertain significance
(Feb 21, 2019)
no assertion criteria provided
49.
GRCh37:
Chr11:32413577
GRCh38:
Chr11:32392031
WT1R246P, R463P, R446P, R67P, R229P, R461P, R209P, R405P, R416P, R441P, R422PNephrotic syndrome, type 4, Acute myeloid leukemiaUncertain significance
(Feb 23, 2023)
criteria provided, multiple submitters, no conflicts
50.
GRCh37:
Chr11:32417887
GRCh38:
Chr11:32396341
WT1R177C, R394C, R377C, R160C, R336C, R353C, R140C, R372C, R392CWilms tumor 1, 11p partial monosomy syndrome, Drash syndrome,
Frasier syndrome, Nephrotic syndrome, type 4, Focal segmental glomerulosclerosis
Uncertain significance
(Aug 30, 2021)
criteria provided, multiple submitters, no conflicts
51.
GRCh37:
Chr11:32413577
GRCh38:
Chr11:32392031
WT1R246Q, R463Q, R67Q, R446Q, R229Q, R405Q, R422Q, R209Q, R416Q, R461Q, R441QWilms tumor 1, 11p partial monosomy syndrome, Aniridia 1,
Nephrotic syndrome, type 4, Drash syndrome, Frasier syndrome,
Mesothelioma, malignant, Meacham syndrome, Wilms tumor 1,
11p partial monosomy syndrome, Drash syndromeFrasier syndrome,
Nephrotic syndrome, type 4, Focal segmental glomerulosclerosis, ...see more
Conflicting interpretations of pathogenicity
(Jul 25, 2022)
criteria provided, conflicting interpretations
52.
GRCh37:
Chr11:32456521
GRCh38:
Chr11:32434975
LOC107982234, WT1P129LAniridia 1, Meacham syndrome, Mesothelioma, malignant,
Wilms tumor 1, Drash syndrome, Nephrotic syndrome, type 4,
11p partial monosomy syndrome, Frasier syndrome, Wilms tumor 1,
Drash syndrome, 11p partial monosomy syndromeFrasier syndrome,
...see more
Uncertain significance
(Aug 21, 2022)
criteria provided, multiple submitters, no conflicts
53.
GRCh37:
Chr11:32450142
GRCh38:
Chr11:32428596
WT1G12R, G229RDrash syndrome, Frasier syndrome, Wilms tumor 1,
11p partial monosomy syndrome, Aniridia 1, Nephrotic syndrome, type 4,
Drash syndrome, Frasier syndrome, Meacham syndrome,
Mesothelioma, malignant, Wilms tumor 111p partial monosomy syndrome,
not provided, ...see more
Uncertain significance
(Dec 6, 2022)
criteria provided, multiple submitters, no conflicts
54.
GRCh37:
Chr11:32413560
GRCh38:
Chr11:32392014
WT1D252Y, D452Y, D469Y, D235Y, D73Y, D411Y, D447Y, D215Y, D422Y, D428Y, D467YDrash syndrome, Nephrotic syndrome, type 4Likely pathogenic
(Mar 16, 2018)
criteria provided, single submitter
55.
GRCh37:
Chr11:32450119
GRCh38:
Chr11:32428573
WT1Drash syndrome, Frasier syndrome, Wilms tumor 1,
11p partial monosomy syndrome, Mesothelioma, malignant, Nephrotic syndrome, type 4,
Aniridia 1, Drash syndrome, Frasier syndrome,
Wilms tumor 1, 11p partial monosomy syndromeMeacham syndrome,
...see more
Likely benign
(Oct 18, 2022)
criteria provided, multiple submitters, no conflicts
56.
GRCh37:
Chr11:32421569
GRCh38:
Chr11:32400023
WT1Drash syndrome, Frasier syndrome, Wilms tumor 1,
11p partial monosomy syndrome, Mesothelioma, malignant, Nephrotic syndrome, type 4,
Aniridia 1, Drash syndrome, Frasier syndrome,
Wilms tumor 1, 11p partial monosomy syndromeMeacham syndrome,
...see more
Likely benign
(Oct 7, 2022)
criteria provided, multiple submitters, no conflicts
57.
GRCh37:
Chr11:32450175
GRCh38:
Chr11:32428629
WT1Drash syndrome, Frasier syndrome, Wilms tumor 1,
11p partial monosomy syndrome, Mesothelioma, malignant, Nephrotic syndrome, type 4,
Aniridia 1, Drash syndrome, Frasier syndrome,
Wilms tumor 1, 11p partial monosomy syndromeMeacham syndrome,
...see more
Likely benign
(May 3, 2022)
criteria provided, multiple submitters, no conflicts
58.
GRCh37:
Chr11:32417925
GRCh38:
Chr11:32396379
WT1P164L, P381L, P147L, P364L, P359L, P379L, P127L, P323L, P340LDrash syndrome, Frasier syndrome, Wilms tumor 1,
11p partial monosomy syndrome, Mesothelioma, malignant, Nephrotic syndrome, type 4,
Aniridia 1, Drash syndrome, Frasier syndrome,
Wilms tumor 1, 11p partial monosomy syndromeMeacham syndrome,
...see more
Uncertain significance
(Feb 25, 2022)
criteria provided, multiple submitters, no conflicts
59.
GRCh37:
Chr11:32417849
GRCh38:
Chr11:32396303
WT1R189S, R406S, R10S, R389S, R172S, R384S, R348S, R152S, R365S, R404SDrash syndrome, Frasier syndrome, Wilms tumor 1,
11p partial monosomy syndrome, Mesothelioma, malignant, Nephrotic syndrome, type 4,
Aniridia 1, Drash syndrome, Frasier syndrome,
Wilms tumor 1, 11p partial monosomy syndromeMeacham syndrome,
...see more
Uncertain significance
(Sep 8, 2021)
criteria provided, multiple submitters, no conflicts
60.
GRCh37:
Chr11:32417909
GRCh38:
Chr11:32396363
WT1Drash syndrome, Frasier syndrome, Wilms tumor 1,
11p partial monosomy syndrome, Mesothelioma, malignant, Nephrotic syndrome, type 4,
Aniridia 1, Drash syndrome, Frasier syndrome,
Wilms tumor 1, 11p partial monosomy syndromeMeacham syndrome,
...see more
Conflicting interpretations of pathogenicity
(Oct 25, 2022)
criteria provided, conflicting interpretations
61.
GRCh37:
Chr11:32456783
GRCh38:
Chr11:32435237
LOC107982234, WT1G42SDrash syndrome, Frasier syndrome, Wilms tumor 1,
11p partial monosomy syndrome, Nephrotic syndrome, type 4, Drash syndrome,
Meacham syndrome, Wilms tumor 1
Conflicting interpretations of pathogenicity
(Oct 29, 2022)
criteria provided, conflicting interpretations
62.
GRCh37:
Chr11:32450048
GRCh38:
Chr11:32428502
WT1S43L, S260L, S6LDrash syndrome, Frasier syndrome, Wilms tumor 1,
11p partial monosomy syndrome, Mesothelioma, malignant, Nephrotic syndrome, type 4,
Aniridia 1, Drash syndrome, Frasier syndrome,
Wilms tumor 1, 11p partial monosomy syndromeMeacham syndrome,
...see more
Uncertain significance
(Sep 20, 2022)
criteria provided, multiple submitters, no conflicts
63.
GRCh37:
Chr11:32456878-32456879
GRCh38:
Chr11:32435332-32435333
LOC107982234, WT1A10Ynot provided, Drash syndrome, Frasier syndrome,
Wilms tumor 1, 11p partial monosomy syndrome, Mesothelioma, malignant,
Nephrotic syndrome, type 4, Aniridia 1, Drash syndrome,
Frasier syndrome, Wilms tumor 111p partial monosomy syndrome,
Meacham syndrome, Hereditary cancer-predisposing syndrome, ...see more
Uncertain significance
(Nov 16, 2022)
criteria provided, multiple submitters, no conflicts
64.
GRCh37:
Chr11:32456704
GRCh38:
Chr11:32435158
LOC107982234, WT1G68EDrash syndrome, Frasier syndrome, Wilms tumor 1,
11p partial monosomy syndrome, Mesothelioma, malignant, Nephrotic syndrome, type 4,
Aniridia 1, Drash syndrome, Frasier syndrome,
Wilms tumor 1, 11p partial monosomy syndromeMeacham syndrome,
...see more
Uncertain significance
(Sep 29, 2022)
criteria provided, multiple submitters, no conflicts
65.
GRCh37:
Chr11:32456566
GRCh38:
Chr11:32435020
LOC107982234, WT1A114VFrasier syndrome, Drash syndrome, Wilms tumor 1,
11p partial monosomy syndrome
Uncertain significance
(Sep 1, 2021)
criteria provided, single submitter
66.
GRCh37:
Chr11:32417808
GRCh38:
Chr11:32396262
WT1H203P, H420P, H403P, H186P, H24P, H166P, H418P, H362P, H379P, H398PNephrotic syndrome, type 4Likely pathogenic
(Sep 18, 2017)
no assertion criteria provided
67.
GRCh37:
Chr11:32410605
GRCh38:
Chr11:32389059
WT1Kidney disorder, Meacham syndrome, not provided,
11p partial monosomy syndrome, Drash syndrome, Frasier syndrome,
Wilms tumor 1, Nephrotic syndrome, type 4, Wilms tumor 1
Conflicting interpretations of pathogenicity
(Sep 14, 2022)
criteria provided, conflicting interpretations
68.
GRCh37:
Chr11:32450081
GRCh38:
Chr11:32428535
WT1F32C, F249CAniridia 1, Drash syndrome, Frasier syndrome,
Meacham syndrome, Mesothelioma, malignant, Nephrotic syndrome, type 4,
Wilms tumor 1, 11p partial monosomy syndrome, Drash syndrome,
Frasier syndrome, Wilms tumor 111p partial monosomy syndrome,
...see more
Uncertain significance
(Mar 15, 2022)
criteria provided, multiple submitters, no conflicts
69.
GRCh37:
Chr11:32456593
GRCh38:
Chr11:32435047
LOC107982234, WT1A105GAniridia 1, Drash syndrome, Frasier syndrome,
Meacham syndrome, Mesothelioma, malignant, Nephrotic syndrome, type 4,
Wilms tumor 1, 11p partial monosomy syndrome, Wilms tumor 1,
Drash syndrome, Frasier syndromeWilms tumor 1,
11p partial monosomy syndrome, not provided, ...see more
Conflicting interpretations of pathogenicity
(Oct 15, 2022)
criteria provided, conflicting interpretations
70.
GRCh37:
Chr11:32456689
GRCh38:
Chr11:32435143
LOC107982234, WT1Q73LInborn genetic diseases, Aniridia 1, Drash syndrome,
Frasier syndrome, Meacham syndrome, Mesothelioma, malignant,
Nephrotic syndrome, type 4, Wilms tumor 1, 11p partial monosomy syndrome,
Hereditary cancer-predisposing syndrome, not providedDrash syndrome,
Frasier syndrome, Wilms tumor 1, 11p partial monosomy syndrome,
...see more
Uncertain significance
(Mar 24, 2023)
criteria provided, multiple submitters, no conflicts
71.
GRCh37:
Chr11:32417906
GRCh38:
Chr11:32396360
WT1Aniridia 1, Drash syndrome, Frasier syndrome,
Meacham syndrome, Mesothelioma, malignant, Nephrotic syndrome, type 4,
Wilms tumor 1, 11p partial monosomy syndrome, Drash syndrome,
Frasier syndrome, Wilms tumor 111p partial monosomy syndrome,
...see more
Benign/Likely benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
72.
GRCh37:
Chr11:32456395
GRCh38:
Chr11:32434849
LOC107982234, WT1G171VDrash syndrome, Frasier syndrome, Wilms tumor 1,
11p partial monosomy syndrome
Likely pathogenic
(Sep 2, 2021)
criteria provided, single submitter
73.
GRCh37:
Chr11:32413565
GRCh38:
Chr11:32392019
WT1R250Q, R467Q, R450Q, R71Q, R233Q, R213Q, R465Q, R409Q, R420Q, R445Q, R426QMesothelioma, malignant, Meacham syndrome, Aniridia 1,
Nephrotic syndrome, type 4, Drash syndrome, Frasier syndrome,
Wilms tumor 1, 11p partial monosomy syndrome, not provided,
Wilms tumor 1, Frasier syndromeDrash syndrome,
Kidney disorder, ...see more
Pathogenic/Likely pathogenic
(Jun 21, 2022)
criteria provided, multiple submitters, no conflicts
74.
GRCh37:
Chr11:32449540
GRCh38:
Chr11:32427994
WT1Drash syndrome, Frasier syndrome, Wilms tumor 1,
11p partial monosomy syndrome, Aniridia 1, Meacham syndrome,
Mesothelioma, malignant, Drash syndrome, Nephrotic syndrome, type 4,
Frasier syndrome, Wilms tumor 111p partial monosomy syndrome,
...see more
Likely benign
(Aug 23, 2022)
criteria provided, multiple submitters, no conflicts
75.
GRCh37:
Chr11:32417885
GRCh38:
Chr11:32396339
WT1Nephrotic syndrome, type 4, Drash syndrome, Frasier syndrome,
Wilms tumor 1, 11p partial monosomy syndrome, Wilms tumor 1,
Meacham syndrome, not specified
Conflicting interpretations of pathogenicity
(Nov 4, 2022)
criteria provided, conflicting interpretations
76.
GRCh37:
Chr11:32421599
GRCh38:
Chr11:32400053
WT1Nephrotic syndrome, type 4, Drash syndrome, Frasier syndrome,
Wilms tumor 1, 11p partial monosomy syndrome, Wilms tumor 1,
Meacham syndrome
Conflicting interpretations of pathogenicity
(Oct 26, 2022)
criteria provided, conflicting interpretations
77.
GRCh37:
Chr11:32410735
GRCh38:
Chr11:32389189
WT1Drash syndrome, Frasier syndrome, Wilms tumor 1,
11p partial monosomy syndrome, Aniridia 1, Meacham syndrome,
Mesothelioma, malignant, Drash syndrome, Nephrotic syndrome, type 4,
Frasier syndrome, Wilms tumor 111p partial monosomy syndrome,
Hereditary cancer-predisposing syndrome, ...see more
Benign/Likely benign
(Oct 27, 2022)
criteria provided, multiple submitters, no conflicts
78.
GRCh37:
Chr11:32456468
GRCh38:
Chr11:32434922
LOC107982234, WT1Q147EHereditary cancer-predisposing syndrome, Frasier syndrome, Wilms tumor 1,
11p partial monosomy syndrome, Drash syndrome, Aniridia 1,
Frasier syndrome, Wilms tumor 1, 11p partial monosomy syndrome,
Drash syndrome, Mesothelioma, malignantNephrotic syndrome, type 4,
Meacham syndrome, ...see more
Uncertain significance
(Jul 31, 2022)
criteria provided, multiple submitters, no conflicts
79.
GRCh37:
Chr11:32417943
GRCh38:
Chr11:32396397
WT1R158H, R375H, R141H, R358H, R334H, R373H, R353H, R121H, R317HWilms tumor 1, Frasier syndrome, Wilms tumor 1,
11p partial monosomy syndrome, Drash syndrome, Meacham syndrome,
Nephrotic syndrome, type 4
Conflicting interpretations of pathogenicity
(Oct 31, 2022)
criteria provided, conflicting interpretations
80.
GRCh37:
Chr11:32449604
GRCh38:
Chr11:32428058
WT1G45D, G262D, G221D, G8DHereditary cancer-predisposing syndrome, Wilms tumor 1, Frasier syndrome,
Wilms tumor 1, 11p partial monosomy syndrome, Drash syndrome,
Meacham syndrome, not provided, Nephrotic syndrome, type 4
Conflicting interpretations of pathogenicity
(Jul 3, 2023)
criteria provided, conflicting interpretations
81.
GRCh37:
Chr11:32456307
GRCh38:
Chr11:32434761
LOC107982234, WT1M200IFrasier syndrome, Wilms tumor 1, 11p partial monosomy syndrome,
Drash syndrome, Aniridia 1, Frasier syndrome,
Wilms tumor 1, 11p partial monosomy syndrome, Drash syndrome,
Mesothelioma, malignant, Nephrotic syndrome, type 4Meacham syndrome,
...see more
Uncertain significance
(Mar 2, 2022)
criteria provided, multiple submitters, no conflicts
82.
GRCh37:
Chr11:32438075
GRCh38:
Chr11:32416529
WT1G109A, G326A, G285A, G72AFrasier syndrome, Wilms tumor 1, 11p partial monosomy syndrome,
Drash syndrome, not specified, not provided
Uncertain significance
(Oct 18, 2022)
criteria provided, multiple submitters, no conflicts
83.
GRCh37:
Chr11:32450136
GRCh38:
Chr11:32428590
WT1P14S, P231SWilms tumor 1, Drash syndrome, Frasier syndrome,
11p partial monosomy syndrome, Aniridia 1, Wilms tumor 1,
Drash syndrome, Frasier syndrome, Nephrotic syndrome, type 4,
11p partial monosomy syndrome, Meacham syndromeMesothelioma, malignant,
not provided, ...see more
Uncertain significance
(Sep 19, 2022)
criteria provided, multiple submitters, no conflicts
84.
GRCh37:
Chr11:32457046
GRCh38:
Chr11:32435500
LOC107982234, WT1Meacham syndrome, Nephrotic syndrome, type 4, Wilms tumor 1
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
85.
GRCh37:
Chr11:32457041
GRCh38:
Chr11:32435495
LOC107982234, WT1Meacham syndrome, Nephrotic syndrome, type 4, Wilms tumor 1
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
86.
GRCh37:
Chr11:32457020
GRCh38:
Chr11:32435474
LOC107982234, WT1Meacham syndrome, Nephrotic syndrome, type 4, Wilms tumor 1
Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
87.
GRCh37:
Chr11:32457016
GRCh38:
Chr11:32435470
LOC107982234, WT1not provided, Meacham syndrome, Nephrotic syndrome, type 4,
Wilms tumor 1
Conflicting interpretations of pathogenicity
(May 1, 2023)
criteria provided, conflicting interpretations
88.
GRCh37:
Chr11:32457012
GRCh38:
Chr11:32435466
LOC107982234, WT1Nephrotic syndrome, type 4, Drash syndrome, Meacham syndrome,
Wilms tumor 1
Conflicting interpretations of pathogenicity
(May 28, 2019)
criteria provided, conflicting interpretations
89.
GRCh37:
Chr11:32457008
GRCh38:
Chr11:32435462
LOC107982234, WT1Meacham syndrome, Nephrotic syndrome, type 4, Wilms tumor 1
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
90.
GRCh37:
Chr11:32457000
GRCh38:
Chr11:32435454
LOC107982234, WT111p partial monosomy syndrome, Meacham syndrome, Nephroblastoma,
Nephrotic syndrome, type 4
Uncertain significance
(Jun 14, 2016)
criteria provided, single submitter
91.
GRCh37:
Chr11:32456996
GRCh38:
Chr11:32435450
LOC107982234, WT1Nephrotic syndrome, type 4, 11p partial monosomy syndrome, Meacham syndrome,
Nephroblastoma
Uncertain significance
(Jun 14, 2016)
criteria provided, single submitter
92.
GRCh37:
Chr11:32456992
GRCh38:
Chr11:32435446
LOC107982234, WT111p partial monosomy syndrome, Meacham syndrome, Nephroblastoma,
Nephrotic syndrome, type 4
Uncertain significance
(Jun 14, 2016)
criteria provided, single submitter
93.
GRCh37:
Chr11:32456988
GRCh38:
Chr11:32435442
LOC107982234, WT111p partial monosomy syndrome, Meacham syndrome, Nephroblastoma,
Nephrotic syndrome, type 4
Uncertain significance
(Jun 14, 2016)
criteria provided, single submitter
94.
GRCh37:
Chr11:32456982
GRCh38:
Chr11:32435436
LOC107982234, WT1Meacham syndrome, Nephrotic syndrome, type 4, Wilms tumor 1
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
95.
GRCh37:
Chr11:32456937
GRCh38:
Chr11:32435391
LOC107982234, WT111p partial monosomy syndrome, Meacham syndrome, Nephroblastoma,
Nephrotic syndrome, type 4
Uncertain significance
(Jun 14, 2016)
criteria provided, single submitter
96.
GRCh37:
Chr11:32456771
GRCh38:
Chr11:32435225
LOC107982234, WT1A46S11p partial monosomy syndrome, Meacham syndrome, Nephroblastoma,
Nephrotic syndrome, type 4
Uncertain significance
(Jun 14, 2016)
criteria provided, single submitter
97.
GRCh37:
Chr11:32456745
GRCh38:
Chr11:32435199
LOC107982234, WT1S54RDrash syndrome, Frasier syndrome, Wilms tumor 1,
11p partial monosomy syndrome, Inborn genetic diseases, Nephrotic syndrome, type 4,
Wilms tumor 1, Meacham syndrome
Uncertain significance
(Jan 24, 2023)
criteria provided, multiple submitters, no conflicts
98.
GRCh37:
Chr11:32456733
GRCh38:
Chr11:32435187
LOC107982234, WT1Frasier syndrome, Wilms tumor 1, 11p partial monosomy syndrome,
Drash syndrome, Hereditary cancer-predisposing syndrome, not provided,
Nephrotic syndrome, type 4, Wilms tumor 1, Meacham syndrome
Conflicting interpretations of pathogenicity
(Aug 1, 2022)
criteria provided, conflicting interpretations
99.
GRCh37:
Chr11:32456660
GRCh38:
Chr11:32435114
LOC107982234, WT1A83S11p partial monosomy syndrome, Meacham syndrome, Nephroblastoma,
Nephrotic syndrome, type 4
Uncertain significance
(Jun 14, 2016)
criteria provided, single submitter
100.
GRCh37:
Chr11:32456622
GRCh38:
Chr11:32435076
LOC107982234, WT111p partial monosomy syndrome, Meacham syndrome, Nephroblastoma,
Nephrotic syndrome, type 4
Uncertain significance
(Jun 14, 2016)
criteria provided, single submitter
Format
Items per page
Sort by
Choose Destination